PHARMACOECONOMIC AND DRUG UTILIZATION STUDY OF ANTIDIABETIC THERAPY IN A TERTIARY CARE TEACHING HOSPITAL OF NORTHERN INDIA
Abstract
Objective: This study was planned to analyze the prescription patterns and compare the cost of antidiabetic drugs in our tertiary care teaching
hospital.
Methods: It was a prospective observational study conducted over a period of 6-month. Data were collected on a predesigned case record form from
patients of diabetes attending medicine outpatient department, and the core prescribing indicators were evaluated. Their pharmacy bill was also
collected and analyzed and percentage variation in the cost of antidiabetic drugs was calculated.
Results: A total of 262 prescriptions were analyzed showing the main age group between 50 and 60 years (39.69%). Out of 262 patients, 141 (53.82%)
were males and 121 (46.18%) were females. 176 (67.17%) prescriptions had 2-5 drugs showing clear evidence of polypharmacy. The total number
of drugs prescribed in 262 prescriptions were 1209, and thus, an average number of drugs prescribed were 4.61/prescription. The most common
antidiabetic drug prescribed was metformin 500 mg in 189 (33.99%) patients, and the most common antidiabetic combination was glimepiride 2 mg
+ metformin 500 mg in 62 (34.63%) patients. Insulin was used in 37 (14.12%) prescriptions. Among other drugs, maximally used were atorvastatin
86 (7.11%) followed by aspirin 54 (4.46%) patients. The percentage cost difference of antidiabetic drugs varies from 40.62 to 633.33. The cost of
monthly therapy for a maximum number of patients was in the cost range INR 100-500 in 148 (56.48%) patients.
Conclusion: The most frequently prescribed antidiabetic drug was metformin and the most frequently used combination used was glimepiride and
metformin. Polypharmacy was also evident in our study, and the cost of monthly antidiabetic therapy was also moderately high.
Keywords: Pharmacoeconomic, Drug utilization, Antidiabetic drugs.
Downloads
References
Definition and Diagnosis of Diabetes Mellitus and Intermediate
Hyperglycemia. Available from: http://www.who.int/diabetes/
publications. [Last accessed on 2016 Feb 25].
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of
diabetes: Estimates for the year 2000 and projections for 2030. Diabetes
Care 2004;27(5):1047-53.
Diabetes and South Asians. Available from: http://www.
indianheartassociation.org/why-indians-why-south-asians/overview/.
[Last accessed on 2016 Feb 25].
Zaveri HG, Mansuri SM, Patel VJ. Use of potentially inappropriate
medicines in elderly: A prospective study in medicine out-patient
department of a tertiary care teaching hospital. Indian J Pharmacol
;42(2):95-8.
Essential Medicines and Health Products. Available from: http://
www.who.int/medicines/areas/rational_use/en/. [Last accessed on
Feb 29].
Gama H. Drug utilization studies. Arq Med 2008;22:69-74.
How to Investigate Drug Use in Health Facilities: Selected Drug Use
Indicators - EDM Research Series No. 007. Available from: http://
ww.apps.who.int/medicinedocs/en/d/Js2289e/3.1.html. [Last accessed
on 2016 Feb 29].
Fox Rushby J, Cairns J. Economic Evaluation. Maidenhead: Open
University Press; 2005.
Ahuja J, Gupta M, Gupta AK, Kohli K. Pharmacoeconomics. Natl Med
J India 2004;17:80-3.
Acharya KG, Shah KN, Solanki ND, Rana DA. Evaluation of
antidiabetic prescriptions, cost and adherence to treatment guidelines:
A prospective, cross-sectional study at a tertiary care teaching hospital.
J Basic Clin Pharm 2013;4(4):82-7.
Das P, Das BP, Rauniar GP, Roy RK, Sharma SK. Drug utilization
pattern and effectiveness analysis in diabetes mellitus at a
tertiary care centre in eastern Nepal. Indian J Physiol Pharmacol
;55:272-80.
Abdi SA, Churi S, Kumar YS. Study of drug utilization pattern of
antihyperglycemic agents in a South Indian tertiary care teaching
hospital. Indian J Pharmacol 2012;44(2):210-4.
Assefa B, Wondimu A, Abrha S, Dinda SC, Demeke B, GebreSamuel
N,
et
al.
Pharmacoeconomic
evaluation
of
antidiabetic
treatment
at
Ayder
Referral
Hospital,
Mekelle,
Ethiopia.
Int
J
Pharm
Sci
Rev Res 2014;25(1):47-52.
Rataboli PV, Dang A. Antimicrobial price variation: Conundrum of
medical profession! J Postgrad Med 2007;53(1):72-4.
de Pablos-Velasco PL, MartÃnez-MartÃn FJ, Molero R, RodrÃguezPerez
F,
GarcÃa-Puente
I,
Caballero
A.
Patterns of
prescription
of
hypoglycaemic
drugs
in Gran Canaria
(Canary islands, Spain) and
estimation
of
the prevalence
of
diabetes mellitus.
Diabetes
Metab
;31(5):457-62.
Kannan, Arshad, Kumar S. A study on drug utilization of oral
hypoglycemic agents in Type-2 diabetic patients. Asian J Pharm Clin
Res 2011;5:60-4.
Sultana G, Kapur P, Aqil M, Alam MS, Pillai KK. Drug utilization of
oral hypoglycemic agents in a university teaching hospital in India.
J Clin Pharm Ther 2010;35(5):267-77.
Johnson JA, Pohar SL, Secnik K, Yurgin N, Hirji Z. Utilization of
diabetes medication and cost of testing supplies in Saskatchewan, 2001.
BMC Health Serv Res 2006;6(3):159.
Sivasankari V, Manivannan E, Priyadarsini SP. Drug utilization pattern
of anti-diabetic drugs in a rural area of Tamil Nadu, South India – A
prospective, observational study. Int J Pharm Biol Sci 2013;4:514-9.
Jadhav NB, Adhav MS. Cost analysis study of oral antidiabetic drugs
available in Indian market. Int J Med Res Health Sci 2013;2(1):63-9.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.